Steven Cohen Xencor Inc Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Xencor Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,023,673 shares of XNCR stock, worth $9.34 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,023,673
Previous 2,177,081
52.98%
Holding current value
$9.34 Million
Previous $50 Million
78.23%
% of portfolio
0.03%
Previous 0.12%
Shares
25 transactions
Others Institutions Holding XNCR
# of Institutions
210Shares Held
78.4MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$101 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$89 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$72 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$56 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$35.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $544M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...